This inventor holds 4 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignees: Pacific Biosciences of California, Inc., Li-Cor, Inc.. Active years: 2005-2012.
Company Filing History:
Years Active: 2005-2012
Title: Dan Draney: Innovator in Nucleic Acid Sequencing Technologies
Introduction
Dan Draney is a notable inventor based in Lincoln, NE (US), recognized for his contributions to the field of nucleic acid sequencing. With a total of 4 patents to his name, Draney has made significant advancements in the methods and systems used for single molecule detection.
Latest Patents
Draney's latest patents include innovative technologies such as flowcell systems for single molecule detection. This invention provides compounds, methods, and systems for sequencing nucleic acid using single molecule detection. By utilizing labeled nanoparticles that exhibit charge-switching behavior, Draney's system enables real-time sequencing as successive detectable moieties flow through a detection channel. The technology allows for the detection of sequencing products while electrically sorting charged molecules, ensuring that cleaved product molecules are detected in isolation without interference from unincorporated nanoparticles.
Another significant patent by Draney is related to charge switch nucleotides. Similar to his previous work, this invention also focuses on sequencing nucleic acid using single molecule detection. The methods and systems developed by Draney facilitate the detection of sequencing products in a microchannel sorting system, enhancing the efficiency and accuracy of DNA sequencing.
Career Highlights
Throughout his career, Dan Draney has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Pacific Biosciences of California, Inc. and Li-Cor, Inc. These experiences have contributed to his expertise and innovation in the field of nucleic acid sequencing.
Collaborations
Draney has collaborated with several professionals in his field, including Bambi L Reynolds and Pamela Sheaff. These partnerships have likely played a role in the development of his patented technologies and advancements in nucleic acid sequencing.
Conclusion
Dan Draney's work in nucleic acid sequencing technologies showcases his innovative spirit and dedication to advancing scientific research. His patents reflect a commitment to improving the methods used in single molecule detection, making significant contributions to the field.